CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Network Study Title CIRB
ALTE24C1 COG Quality of End-of-Life Care for Children with Cancer: A COG Groupwide Observational Study Pediatric CIRB
AMC-107 AMC A Phase 2 Trial of Ixazomib for Kaposi Sarcoma Adult CIRB - Late Phase Emphasis
AMC-108 AMC Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma Adult CIRB - Late Phase Emphasis
AMC-110 AMC Risk-Adapted Therapy for HIV-Associated Anal Cancer Adult CIRB - Early Phase Emphasis
AMC-111 AMC Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living with HIV: A Feasibility Study Adult CIRB - Late Phase Emphasis
AMC-112 AMC Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma Adult CIRB - Late Phase Emphasis
AMC-115 AMC Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium Adult CIRB - Late Phase Emphasis
AMC-118 AMC A Phase II Study of Nirogacestat in Patients with Kaposi Sarcoma Adult CIRB - Late Phase Emphasis
AMC-119 AMC Epcoritamab in Combination with Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL) (BEDROCK Study) Adult CIRB - Late Phase Emphasis
AMC-120 AMC A Feasibility Study of Glofitamab plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma Adult CIRB - Early Phase Emphasis